dihydroxyphenylalanine has been researched along with Spasm in 18 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Spasm: An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaw, KM | 1 |
| Hunter, KR | 1 |
| Stern, GM | 1 |
| Coppen, A | 1 |
| Metcalfe, M | 1 |
| Carroll, JD | 1 |
| Morris, JG | 1 |
| Pinder, RM | 1 |
| Higgins, DC | 1 |
| Haidri, NH | 1 |
| Wilbourn, AJ | 1 |
| Coleman, MP | 1 |
| Barnet, A | 1 |
| Bird, MT | 1 |
| Paulson, GW | 1 |
| Martin, WE | 1 |
| Resch, JA | 1 |
| Baker, AB | 1 |
| Pedersen, E | 1 |
| Dietrichson, P | 2 |
| Gormsen, J | 1 |
| Arlien-Soborg, P | 1 |
| Coles, WH | 1 |
| Diemath, HE | 1 |
| Enge, S | 1 |
| Lechner, H | 1 |
| Roth, JC | 1 |
| Epstein, CJ | 1 |
| Guggenheim, MA | 1 |
| Couch, JR | 1 |
| Weinberg, W | 1 |
| Guidetti, B | 1 |
| Giuffrè, R | 1 |
| Hartmann-von Monakow, K | 2 |
| Ferrini, R | 1 |
| Glässer, A | 1 |
| Barrett, RE | 1 |
| Yahr, MD | 1 |
| Duvoisin, RC | 1 |
1 review available for dihydroxyphenylalanine and Spasm
| Article | Year |
|---|---|
The pharmacotherapy of Parkinsonism.
Topics: Acetylcholine; Antiparkinson Agents; Atropa belladonna; Brain; Dihydroxyphenylalanine; Dopamine; His | 1972 |
1 trial available for dihydroxyphenylalanine and Spasm
| Article | Year |
|---|---|
Levodopa and L-tryptophan therapy in Parkinsonism.
Topics: Aged; Depression; Dihydroxyphenylalanine; Female; Gait; Homovanillic Acid; Humans; Hydroxyindoleacet | 1972 |
16 other studies available for dihydroxyphenylalanine and Spasm
| Article | Year |
|---|---|
Medical treatment of spasmodic torticollis.
Topics: Adult; Dihydroxyphenylalanine; Follow-Up Studies; Humans; Male; Spasm; Torticollis | 1972 |
Muscle silent period in Parkinson's disease.
Topics: Aged; Dihydroxyphenylalanine; Electromyography; Female; Humans; Male; Middle Aged; Muscle Contractio | 1971 |
L-dopa reversal of muscular spasm, vomiting and insomnia in a patient with an atypical form of familial dystonia.
Topics: Adolescent; Blood Platelets; Child; Diarrhea; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; | 1969 |
The rigid form of Huntington's chorea.
Topics: Adult; Age Factors; Amantadine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Movement | 1971 |
Juvenile parkinsonism.
Topics: Adult; Age Factors; Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine; Humans; Male; M | 1971 |
Measurement of phasic and tonic stretch reflexes in antispastic and antiparkinsonian therapy.
Topics: Achilles Tendon; Action Potentials; Aminobutyrates; Computers, Analog; Cryosurgery; Depression, Chem | 1974 |
Essential blepharospasm.
Topics: Age Factors; Diagnosis, Differential; Dihydroxyphenylalanine; Ethanol; Eyelid Diseases; Facial Muscl | 1973 |
EEG depth leads during stereotaxic brain surgery. A report on 117 cases (5 target points, effects of 13 different drugs).
Topics: Amides; Amygdala; Antimetabolites; Asparagine; Benzoates; Brain; Brain Diseases; Cerebrovascular Cir | 1970 |
Infantile spasms and hypopigmented macules. Early manifestations of tuberous sclerosis.
Topics: Biopsy; Catechol Oxidase; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Histocytochemistr | 1971 |
Motor dysfunction as a permanent complication of methanol ingestion. Presentation of a case with a beneficial response to levodopa treatment.
Topics: Adolescent; Dihydroxyphenylalanine; Female; Humans; Methanol; Motor Cortex; Movement Disorders; Opti | 1971 |
A year's experience of L-DOPA in the treatment of Parkinson's disease.
Topics: Adult; Age Factors; Aged; Dihydroxyphenylalanine; Female; Functional Laterality; Humans; Hypotension | 1971 |
[Treatment of the Parkinson syndrome with amantadine].
Topics: Adult; Aged; Amantadine; Arteriosclerosis; Cognition Disorders; Dihydroxyphenylalanine; Drug Interac | 1971 |
Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8beta-carbobenzyloxy-aminomethyl-10alpha-ergoline. Interference with amphetamine and DOPA.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Central Nervous System; Dihydroxyphenylalanine; Fever; Mi | 1965 |
[Therapy of extrapyramidal-motor symptoms. Drug treatment].
Topics: Alkaloids; Atropa belladonna; Dihydroxyphenylalanine; Extrapyramidal Tracts; Humans; Monoamine Oxida | 1969 |
Quantitative appraisal of L-dopa in Parkinsonism.
Topics: Dihydroxyphenylalanine; Electromyography; Humans; Parkinson Disease; Spasm; Tremor | 1970 |
Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa.
Topics: Acute Disease; Adolescent; Adult; Child; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Fema | 1970 |